Potassium%2525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520chloride

# Potassium Chloride ## Overview Potassium chloride (KCl) is an electrolyte supplement used to treat or prevent hypokalemia. It is available in various formulations, including oral tablets, capsules, powders, and intravenous solutions. ## Primary Indications * Treatment of hypokalemia (serum potassium < 3.5 mEq/L). * Prevention of hypokalemia, particularly in patients receiving potassium-wasting diuretics or with conditions predisposing to potassium loss. ## Adult Dosing * **Treatment of Hypokalemia:** * Oral: 20-100 mEq per day, divided into 1-4 doses. Higher doses may be required in severe cases, but should be administered with caution and close monitoring. * Intravenous: 10-20 mEq per hour, not to exceed 40 mEq per day in most patients. In life-threatening hypokalemia (serum potassium < 2.5 mEq/L), infusion rates up to 40 mEq/hour may be used with continuous cardiac monitoring and frequent serum potassium checks. * **Prevention of Hypokalemia:** * Oral: 20-40 mEq per day, divided into 1-2 doses. Maximum oral dose is generally 100 mEq/day, but may be higher under strict medical supervision. Maximum IV infusion rate is typically 10 mEq/hour peripherally and up to 40 mEq/hour centrally, depending on the severity of hypokalemia and cardiac monitoring. **Consult local protocols for specific IV infusion rates and concentrations.** ## Pediatric Dosing * **Treatment of Hypokalemia:** * Oral: 2-5 mEq/kg per day, divided into 1-4 doses. * Intravenous: 0.5-1 mEq/kg per dose, infused over 1-3 hours. Maximum daily dose: 3-4 mEq/kg/day. * **Prevention of Hypokalemia:** * Oral: 1-2 mEq/kg per day. **Maximum oral daily dose in pediatrics is generally 100 mEq/day.** **Intravenous dosing in pediatric patients requires careful calculation based on weight and serum potassium levels, and often follows specific institutional guidelines.** ## Dose Adjustments * **Renal Impairment:** Dose reduction is necessary. Potassium chloride is generally contraindicated in severe renal impairment due to the risk of hyperkalemia. * **Hepatic Impairment:** No specific dose adjustment is usually required, but caution is advised due to potential for electrolyte imbalances. ## Contraindications * Hyperkalemia (serum potassium > 5.0 mEq/L). * Conditions causing elevated serum potassium, such as renal failure, Addison's disease, or untreated Addison's disease. * Certain gastrointestinal conditions, such as esophageal compression, delayed gastric emptying, or intestinal obstruction (for oral formulations). * Concurrent use of potassium-sparing diuretics or ACE inhibitors in patients with impaired renal function may increase the risk of hyperkalemia. ## Adverse Effects * **Common:** Nausea, vomiting, diarrhea, abdominal pain, flatulence. * **Serious:** Hyperkalemia (can be life-threatening), cardiac arrhythmias, cardiac arrest, ECG changes (peaked T waves, prolonged QT interval, loss of P waves, widening QRS), muscle weakness, paralysis, gastrointestinal ulceration, bleeding, perforation, and obstruction (especially with sustained-release oral formulations or rapid IV infusion). ## Key Drug Interactions * **Potassium-sparing diuretics (e.g., spironolactone, amiloride):** Increased risk of hyperkalemia. * **ACE inhibitors and ARBs:** Increased risk of hyperkalemia. * **NSAIDs:** May reduce the antihypertensive effect of potassium supplements and increase the risk of hyperkalemia. * **Digoxin:** Hyperkalemia can increase digoxin toxicity; hypokalemia can increase digoxin toxicity. * **Anticholinergic drugs:** May increase the risk of gastrointestinal adverse effects. ## Monitoring * Serum potassium levels: Frequently, especially during initiation of therapy, dose adjustments, or in patients with renal impairment or severe hypokalemia. * Renal function (BUN, creatinine). * ECG: Especially in patients receiving IV potassium or those with pre-existing cardiac conditions. * Signs and symptoms of hyperkalemia (e.g., muscle weakness, palpitations, confusion). * Signs and symptoms of gastrointestinal distress or bleeding with oral formulations. ## Clinical Pearls * Oral potassium chloride should be taken with meals and a full glass of water to minimize gastrointestinal upset. * Sustained-release oral formulations may reduce gastrointestinal irritation but can be associated with esophageal irritation or obstruction if not taken with adequate fluid. * Intravenous potassium must be diluted and infused slowly to prevent cardiac arrhythmias and local vein irritation. Never administer as an IV push. * Correcting severe hypokalemia (serum potassium < 2.5 mEq/L) often requires IV administration. * When switching between oral and IV formulations, account for differences in absorption and bioavailability. *** *This information is intended for healthcare professionals. Always consult the most current prescribing information and relevant clinical guidelines before making treatment decisions.*